(Q38254646)

1 September 2017

1 reference

title

A global safety evaluation of etodolac (English)

1 reference

1 September 2017

Karbowski A

1

1 reference

1 September 2017

1 March 1989

1 reference

1 September 2017

Clinical Rheumatology

1 reference

1 September 2017

8 Suppl 1

1 reference

1 September 2017

73-79

1 reference

Minimum effective dose of etodolac for the treatment of rheumatoid arthritis

1 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02214112

Etodolac versus naproxen in rheumatoid arthritis: a double-blind crossover study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02214112

The efficacy of etodolac for patients with pain following oral surgery

21 January 2018

1 reference

12 December 2020

Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study

1 reference

12 December 2020

Etodolac in postsurgical pain: a double-blind dose-ranging efficacy study with aspirin and placebo

1 reference

12 December 2020

Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: a 12-week study

1 reference

12 December 2020

Twelve-week study of etodolac, aspirin, and placebo in patients with rheumatoid arthritis

1 reference

12 December 2020

Comparative efficacy of etodolac and placebo in rheumatoid arthritic patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02214112

1 reference

1 September 2017

1 reference

PubMed ID

2525986